Bayer AG aims to claim China’s OTC market throne with its recent acquisition of an OTC and traditional Chinese medicine company, but other firms also have their sights set on expanding in the countr
Bayer AG aims to claim China’s OTC market throne with its recent acquisition of an OTC and traditional Chinese medicine company, but other firms also have their sights set on expanding in the countr
SHANGHAI – With the recent acquisition of a Chinese over-the-counter and traditional Chinese medicine company, Bayer AG is aiming to claim the throne of the OTC market in China. However, it will n
IN VITRO DIAGNOSTICS Mergers & Acquisitions Amgen Inc. deCode genetics EHF Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash. (Dec.) DeCODE was fo